Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,625 | -5,866 | -2,808 | -9,948 | -7,305 |
| Depreciation Amortization | 85 | 54 | 25 | 81 | 58 |
| Accounts receivable | 48 | 12 | 24 | -48 | -40 |
| Accounts payable and accrued liabilities | -87 | 34 | 291 | -350 | -466 |
| Other Working Capital | -769 | -578 | -126 | -513 | -737 |
| Other Operating Activity | 810 | 443 | -86 | 2,176 | 1,916 |
| Operating Cash Flow | $-8,537 | $-5,901 | $-2,679 | $-8,603 | $-6,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -209 | -155 | -62 | -67 | -32 |
| Investing Cash Flow | $-209 | $-155 | $-62 | $-67 | $-32 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,351 | 13,351 | 13,351 | 11,587 | 11,587 |
| Other Financing Activity | -1,327 | -1,327 | -1,327 | -52 | -27 |
| Financing Cash Flow | $12,023 | $12,023 | $12,024 | $11,535 | $11,560 |
| Beginning Cash Position | 6,901 | 6,901 | 6,901 | 4,036 | 4,036 |
| End Cash Position | 10,178 | 12,869 | 16,184 | 6,901 | 8,991 |
| Net Cash Flow | $3,277 | $5,968 | $9,283 | $2,865 | $4,954 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,537 | -5,901 | -2,679 | -8,603 | -6,574 |
| Capital Expenditure | -209 | -155 | -62 | -67 | -32 |
| Free Cash Flow | -8,746 | -6,056 | -2,741 | -8,670 | -6,606 |